image_pdfimage_print

Welcome Saara Huoponen

Posted Posted in News

ESiOR Oy gets stronger… We welcome the 10th member of our team! Namely, ISPOR-awarded Saara Huoponen has joined our team as health economic consultant and Market Access specialist. Saara has earlier worked eg as Pricing and Reimbursement Officer at Farenta Oy. In addition to the rare double ISPOR experience as the Scientific Review Committee Co-Chair, […]

Akseli Kivioja and Satu Rauhala: stronger service portfolio at ESiOR

Posted Posted in News

Well-known Market Access professionals, Satu Rauhala and Akseli Kivioja, joined ESiOR on August 7th, 2017. Their joint experience is unique: Finnish Pharmaceuticals Pricing Board, pharma industry, pharmaceutical research, and consultancy. When you are in need of experience, expertise and broad vision, please don’t hesitate to contact us. Additional information: Akseli Kivioja, Satu Rauhala or Erkki Soini

Professor pharmacoeconomics

Posted Posted in News

Janne Martikainen, PhD (health economics), Adjunct Professor (economic evaluation of pharmaceuticals) in Turku University and one of ESiOR’s health economists and partners is now also the new Professor of pharmacoeconomics in the University of Eastern Finland.

Development project

Posted Posted in News

Development of business and services portfolio Project’s goals are to innovate and develop new business, support business growth and strengthen national and international competitiveness of the company. The project results in a growth company with significantly more versatile portfolio of business services and products targeted to a significantly wider spectrum of clients. In addition, the […]

Nordic RWD conference, meet us there

Posted Posted in News

ESiOR Ltd takes part in Nordic conference on Real World Data – Collaboration between pharma industry and Academia on November 29-30, 2016, in Helsinki. We have waited for the event with great interest, because we feel that Expert Solutions in Outcomes Research (ESiOR) has a lot to offer. Real world data (RWD) can depict what […]

Essential ESiOR: 5 presentations at ISPOR

Posted Posted in News

It is time for celebration. ESiOR will participate in International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Vienna for the tenth time. ISPOR is a must for everyone interested in pharmacoeconomics and outcomes research. Let’s meet in the congress! Ongoing regional government reform and social welfare and healthcare (SOTE) reform will […]

ESiOR at Terveys ja talous -päivät

Posted Posted in News

ESiOR participated in Terveys ja talous -päivät (Finnish seminar on health and economics) and presented a new study on cost-effectiveness of atrial fibrillation treatments “Eteisvärinän antikoagulaatiohoito muutoksen myllerryksessä: Muuttuvatko kokonaiskustannus ja vaikuttavuus maksajan mukana?” (in Finnish).

4th Nordic Conference on Research in Patient Safety and Quality in Healthcare

Posted Posted in News

ESiOR Oy participates in the 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare 19th-20th May 2016 in Hotel Puijonsarvi, Kuopio. We will be very pleased  to meet you there! Our expertise in social and healthcare sector include e.g. the following assessments : costs, effectiveness, cost-effectiveness, budget impact, patient paths and processes. Our services […]

STM workshop on SoTe data legislation

Posted Posted in News

ESiOR had the privilege to participate in the excellent working group meeting “Management, steering and surveillance by knowledge” organised by the Finnish Ministry of Social Affairs and Health in Helsinki on February 16, 2016. The meeting sought to gather opinions and to gain understanding on the various aspects and challenges that should be taken into […]

Seminar on utilization of SOTE information

Posted Posted in News

ESiOR participated actively in Utilization of SOTE (social welfare and health care) information seminar , which took place 27th January 2016 in Helsinki, Finland. CEO Erkki Soini took part in a Finnish panel discussion about Companies and health data led by Kuopio Innovation as a representative of health economics. If you missed the seminar, you can find government’s targets […]